Raymond James & Associates’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,000
| Closed | -$10K | – | 3706 |
|
|
2019
Q4 | $10K | Hold |
2,000
| – | – | ﹤0.01% | 3540 |
|
|
2019
Q3 | $16K | Hold |
2,000
| – | – | ﹤0.01% | 3468 |
|
|
2019
Q2 | $15K | Hold |
2,000
| – | – | ﹤0.01% | 3483 |
|
|
2019
Q1 | $16K | Hold |
2,000
| – | – | ﹤0.01% | 3466 |
|
|
2018
Q4 | $16K | Hold |
2,000
| – | – | ﹤0.01% | 3402 |
|
|
2018
Q3 | $31K | Hold |
2,000
| – | – | ﹤0.01% | 3458 |
|
|
2018
Q2 | $18K | Hold |
2,000
| – | – | ﹤0.01% | 3435 |
|
|
2018
Q1 | $18K | Hold |
2,000
| – | – | ﹤0.01% | 3323 |
|
|
2017
Q4 | $20K | Hold |
2,000
| – | – | ﹤0.01% | 3256 |
|
|
2017
Q3 | $31K | Hold |
2,000
| – | – | ﹤0.01% | 3212 |
|
|
2017
Q2 | $18K | Buy |
2,000
+720
| +56% | +$6.48K | ﹤0.01% | 3159 |
|
|
2017
Q1 | $34K | Buy |
+1,280
| New | +$34K | ﹤0.01% | 3087 |
|